Compare HCA Health Inc (HCA) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs The Coca-Cola Co K — how do they compare? HCA Health Inc trades at $411.81 (market cap $89.64B), while The Coca-Cola Co K trades at $86.53 (market cap $373.76B). The key difference: The Coca-Cola Co K is far larger — about 4.2× HCA Health Inc's market cap, and The Coca-Cola Co K pays the higher dividend (2.44%). Which is the better fit depends on your goals.
| HCA | KO | |
|---|---|---|
Market Cap | $89.64B | $373.76B |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $89.08 |
52-Week Low | $361.32 | $65.67 |
Enterprise Value | $140.18B | $400.93B |
Dividend Yield | 0.75% | 2.44% |
Volume | — | 14,630,257 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $413.36, up 1.09% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $449.93. The company reported strong Q2 2026 earnings of $7.59 per share, beating estimates, and has shown consistent revenue growth, reaching $75.60 billion in 2025. Recent corporate actions include dividend payments of $0.78 per share, while news highlights executive appointments and ongoing legal investigations.
The stock presents a compelling investment case with attractive valuation multiples like a P/E of 13.86 and robust profitability, but faces risks from legal probes and high debt levels. Upside potential is supported by analyst optimism and solid operational cash flow, though investors should monitor expense pressures and regulatory developments.
Coca-Cola (KO) trades at $86.48, down 0.65% on the day, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.97 exceeding the $0.92 estimate, and maintains robust profitability with a 28.56% net margin. Recent news highlights institutional buying and stable demand trends, while dividends continue with a $0.53 payout.
The outlook is positive with a consensus price target of $95.83 implying 11% upside, driven by earnings momentum and dividend reliability. Risks include regional demand volatility and high debt levels, but analyst sentiment is bullish with 60% buy ratings. The stock presents a steady growth opportunity with defensive income characteristics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
